Genetic Pathways Effecting Crossover Control and Meiotic Recombination in Mammals

影响哺乳动物交叉控制和减数分裂重组的遗传途径

基本信息

  • 批准号:
    8604715
  • 负责人:
  • 金额:
    $ 28.9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-04-05 至 2016-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In humans, 50% of all spontaneous miscarriages are due to non-disjunction errors at the first meiotic division, while 90% of Down syndrome cases can be attributed to errors in maternal meiosis I. The predominant cause of these errors lies with misregulation of the recombination events that define meiosis. Reciprocal recombination, or crossing over, occurs during prophase I and is essential for tethering homologous chromosomes together until the first meiotic division. Recombination is initiated by the formation of DNA double-strand breaks (DSB) that are then processed to form either crossovers (CO) or noncrossovers (NCO). CO frequency and placement is tightly regulated to ensure at least one CO per chromosome and to prevent closely spaced CO, a process known as interference, while selection of COs from a large pool of DSBs is subject to stringent crossover homeostasis. Both interference and crossover homeostasis are thought to arise early in the DSB repair process. Two CO pathways have been described in a number of organisms, including mammals. The class I pathway is regulated by the meiotic components of the DNA Mismatch repair (MMR) family (MSH4-MSH5 and MLH1-MLH3 heterodimers), while the class II pathway is regulated by MUS81-EME1. Studies in the PI's laboratory have determined that there is a degree of integration between the two pathways that appears to be unique to mammals, such that the Class II pathway leads to an increase in Class I crossover intermediates, as demonstrated by the increase in MLH1-MLH3 appearance on meiotic chromosomes. This increased flux through the Class I pathway maintains the final chiasmata count; presumably because these additional Class I events replace those Class II events that can no longer occur in the absence of MUS81. Alternatively, it is possible that a third crossover pathway is recruited to maintain the final chiasmata tally, since double mutants for both Mlh3 and Mus81 still retain residual chiasmata. In either case, this integration between CO pathways occurs late in prophase I, indicating a novel mechanism for monitoring final CO output that is temporally distinct from the earlier interference and homeostasis events. Studies in this proposal are aimed at understanding how this integration between the two pathways is achieved. Preliminary data presented herein point towards two possible mediators of these events: BLM helicase, and the newly-identified BTBD12 endonuclease, a putative target of the ATM kinase. Our overall hypothesis is that the choice of CO pathway may involve integrated signaling through two regulators, BLM and BTBD12, each of which serve either to provide the appropriate substrate for CO processing and/or to divert structures between pathways, as needed. The specific aims are: (1) to examine the role of BLM at different stages of meiotic prophase I in mammalian germ cells; (2) to understand the meiotic role of BTBD12 and how this function is regulated by ATM kinase; and (3) to explore the mechanisms by which the two CO pathways are integrated in late prophase I to produce the appropriate tally of chiasmata.
描述(申请人提供):在人类,50%的自发性流产是由于第一次减数分裂时的不分离错误,而90%的唐氏综合症病例可以归因于母体减数分裂I的错误。这些错误的主要原因是定义减数分裂的重组事件的错误调节。互换重组或交换发生在前期I,对于将同源染色体系在一起直到第一次减数分裂是必不可少的。重组是由DNA双链断裂(DSB)的形成启动的,然后DNA双链断裂被加工成交叉(CO)或非交叉(NCO)。CO的频率和位置受到严格的调控,以确保每条染色体至少有一个CO,并防止紧密间隔的CO,这一过程被称为干扰,而从大量DSB中选择CO受到严格的交叉稳态的影响。干扰和交叉稳态都被认为是在DSB修复过程的早期出现的。已经在包括哺乳动物在内的许多生物体中描述了两条CO途径。I类途径由DNA错配修复(MMR)家族的减数分裂组分(MSH4-MSH5和MLH1-MLH3异源二聚体)调控,而II类途径由MUS81-EME1调控。PI实验室的研究已经确定,这两条途径之间存在一定程度的整合,这似乎是哺乳动物所特有的,因此,II类途径导致I类交叉中间产物的增加,这从减数分裂染色体上MLH1-MLH3出现的增加可见一斑。通过I类通路的这种增加的流量维持了最终的交叉计数;可能是因为这些额外的I类事件取代了那些在没有MUS81的情况下不能再发生的II类事件。或者,由于M1h3和MUS81的双突变体仍然保留残留的交叉,因此可能会招募第三个交叉途径来维持最终的交叉计数。在任何一种情况下,CO通路之间的这种整合都发生在前期I的晚期,这表明了一种新的机制来监测最终的CO输出,这种机制在时间上与早期的干扰和动态平衡事件不同。这项建议中的研究旨在了解这两条途径之间的这种整合是如何实现的。这里提供的初步数据指向了这些事件的两个可能的介体:BLM解旋酶和新发现的BTBD12内切酶,它可能是ATM激酶的靶标。我们的总体假设是,CO途径的选择可能涉及通过两个调节子BLM和BTBD12的整合信号,每个调节子都为CO加工提供合适的底物和/或根据需要在途径之间转移结构。其具体目的是:(1)研究BLM在哺乳动物生殖细胞减数分裂前期I的不同阶段中的作用;(2)了解BTBD12的减数分裂作用以及ATM激酶如何调节这一功能;以及(3)探索这两条CO通路在前期I晚期整合的机制,以产生适当的交叉计数。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Paula Elaine Cohen其他文献

Paula Elaine Cohen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Paula Elaine Cohen', 18)}}的其他基金

Investigating the role of bromodomain-containing proteins in the production of viable spermatozoa and male fertility
研究含溴结构域蛋白在活精子产生和男性生育能力中的作用
  • 批准号:
    10157200
  • 财政年份:
    2021
  • 资助金额:
    $ 28.9万
  • 项目类别:
Spermatogenic gene regulation and infertility
生精基因调控与不育
  • 批准号:
    10157198
  • 财政年份:
    2021
  • 资助金额:
    $ 28.9万
  • 项目类别:
Spermatogenic gene regulation and infertility
生精基因调控与不育
  • 批准号:
    10398873
  • 财政年份:
    2021
  • 资助金额:
    $ 28.9万
  • 项目类别:
Investigating the role of bromodomain-containing proteins in the production of viable spermatozoa and male fertility
研究含溴结构域蛋白在活精子产生和男性生育能力中的作用
  • 批准号:
    10398876
  • 财政年份:
    2021
  • 资助金额:
    $ 28.9万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10398875
  • 财政年份:
    2021
  • 资助金额:
    $ 28.9万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10157199
  • 财政年份:
    2021
  • 资助金额:
    $ 28.9万
  • 项目类别:
Spermatogenic gene regulation and infertility
生精基因调控与不育
  • 批准号:
    10615691
  • 财政年份:
    2021
  • 资助金额:
    $ 28.9万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10615692
  • 财政年份:
    2021
  • 资助金额:
    $ 28.9万
  • 项目类别:
Investigating the role of bromodomain-containing proteins in the production of viable spermatozoa and male fertility
研究含溴结构域蛋白在活精子产生和男性生育能力中的作用
  • 批准号:
    10615696
  • 财政年份:
    2021
  • 资助金额:
    $ 28.9万
  • 项目类别:
2020 Meiosis Gordon Research Conference and Gordon Research Seminar
2020年减数分裂戈登研究大会暨戈登研究研讨会
  • 批准号:
    9980585
  • 财政年份:
    2020
  • 资助金额:
    $ 28.9万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 28.9万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 28.9万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.9万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.9万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 28.9万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.9万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 28.9万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 28.9万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 28.9万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.9万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了